Introduction to supplement
Intravenous therapy and intravenous access ecent years have seen increasing emphasis on preventing healthcare associated infections (HCAIs) associated with vascular access. There have been a number of drivers for this, including the publication of guidelines providing evidencebased recommendations for practice that can, when implemented, signifi cantly reduce the risk of these infections. In England, the selection of bloodstream infections caused by meticillin resistant Staphylococcus aureus (MRSA) as a performance indicator has led to considerable work in this area. Detailed root-cause analysis of individual infections in many organisations identifi ed areas where practice could be improved, including practice relating to vascularaccess devices. As a result many innovative developments have been made in clinical practice, and some of these are described within this supplement. Product manufacturers have also supported this work by focusing on developing products that are designed to reduce the likelihood of infection developing.
Notable successes such as the achievement of the target to reduce MRSA bacteraemias by half in the NHS in England and the Institute for Healthcare Improvement's patient safety campaigns in the United States have helped to foster the realisation that many more of these infections are preventable than may previously have been realised.
One consequence of the increased emphasis on preventing infections relating to vascular access devices is the need for enhanced collaborative working between specialists in infection prevention and control and specialists in vascular access therapy.
The Infection Prevention Society has recognised this need, and in response has launched the IPS IV Forum. This forum provides a mechanism for networking with other colleagues and exchanging information relating to vascular access in order to improve patient safety. More details of the IPS IV Forum can be found on the website -www.ips. uk.net The IPS is also running a full day's programme devoted to the topic at Infection Prevention 09, this year's annual IPS conference.
This Supplement to the Journal of Infection Prevention contains a variety of articles on the topics of intravenous therapy and intravenous access. They range from an account of the pioneer of intravenous therapy to descriptions of the many different vascular devices currently in use to an evaluation of the latest antimicrobial dressing. We hope that they will be of interest and use to any practitioner seeking to reduce the risk of infection associated with vascular access in health care. The Editorial Board would like to extend their thanks to Andrew Jackson, Consultant Nurse in IV Therapy and Care at the Rotherham NHS Foundation Trust, for commissioning these articles on our behalf.
